ATHOS KG

Activity by year

20222023202420252026

AcquisitionInvestment

Dec 13, 2022INVESTMENTSouth Carolina, United States, United States$90.0Mops 2024
SHL Medical secures financial support for drug delivery growth strategy
SHL Medical has secured financial support from a consortium of investors including EQT Future and ATHOS to execute its 2030 growth strategy, which includes adding production capacity in the U.S. and Europe. The company previously announced plans to invest $90 million in a new manufacturing plant in South Carolina, due to start operations in 2024.
SHL Medical EQT investor ATHOS KG investor #Medical Devices fiercepharma.com
Mar 29, 2022ACQUISITIONGermany$715.0M
Formycon acquires biosimilar assets from ATHOS KG in strategic partnership
Formycon AG and ATHOS KG have agreed to merge biosimilar development activities. Formycon will acquire 100% of rights in FYB202, the 50% stake in FYB201, and Bioeq GmbH for a cumulative consideration of approximately EUR 650 million. ATHOS will become the largest shareholder with about 26.6% of Formycon.
Formycon AG acquirer ATHOS KG target Bioeq GmbH target #Medical Devices formycon.com

Acquired by

Invested in

Loading…